Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:1253-1259

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fareh, J.
Right arrow Articles by Thibault, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fareh, J.
Right arrow Articles by Thibault, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*SODIUM CHLORIDE
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1997;30:1253-1259.)
© 1997 American Heart Association, Inc.


Articles

Cardiac Type-1 Angiotensin II Receptor Status in Deoxycorticosterone Acetate–Salt Hypertension in Rats

Jeannette Fareh; Rhian M. Touyz; Ernesto L. Schiffrin; Gaetan Thibault

From the Medical Research Council Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal (Quebec, Canada).

Correspondence to Gaetan Thibault, Clinical Research Institute of Montreal, 110 Pine Ave West, Montreal, Quebec, Canada H2W 1R7. Email thibaug{at}ircm.umontreal.ca

Abstract The regulation of angiotensin II (Ang II) receptors and Ang II–induced modulation of intracellular Ca2+ concentration in cardiac cells from hearts of experimentally induced hypertensive deoxycorticosterone acetate (DOCA)–salt and control unilaterally nephrectomized (Uni-Nx) Sprague-Dawley rats was assessed. Ang II receptor density and intracellular Ca2+ concentration measurements were examined in adult ventricular myocytes and fibroblasts by radioligand binding assay and digital imaging using fura 2 methodology, respectively. Four-week DOCA-salt treatment induced hypertension associated with cardiac hypertrophy. Ang II binding studies demonstrated that adult ventricular myocytes and fibroblasts possess mainly the AT1 subtype receptor. Moreover, DOCA-salt hypertension was associated with a 1.8-fold increase in Ang II–specific binding compared with myocytes from Uni-Nx control rats. Intracellular Ca2+ responses induced by increasing Ang II concentrations (10-12 to 10-4 mol/L) were significantly enhanced in cardiomyocytes from DOCA-salt rats. The effects of Ang II on intracellular Ca2+ spike frequency were unaltered in cardiomyocytes from DOCA-salt–hypertensive rats. The density of AT1 subtype receptors was not modified in ventricular fibroblasts after DOCA-salt treatment. Ang II increased intracellular Ca2+ concentration similarly in ventricular fibroblasts from normal and hypertensive rats. In conclusion, DOCA-salt hypertension is characterized by an increased AT1 receptor density and intracellular calcium responses in ventricular myocytes, whereas in ventricular fibroblasts the AT1 receptor status is unaltered. These findings report for the first time the cardiac cell–specific implication of Ang II and the intracellular calcium signaling pathway stimulated by the AT1 receptor in cardiac hypertrophy in DOCA-salt–hypertensive rats.


Key Words: hypertrophy • myocytes • fibroblasts • calcium




This article has been cited by other articles:


Home page
CirculationHome page
V. S. Chhokar, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, L. K. Myers, Z. Xing, R. A. Smith, I. C. Gerling, and K. T. Weber
Hyperparathyroidism and the Calcium Paradox of Aldosteronism
Circulation, February 22, 2005; 111(7): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. Thibault, M.-J. Lacombe, L. M. Schnapp, A. Lacasse, F. Bouzeghrane, and G. Lapalme
Upregulation of alpha 8beta 1-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta 1
Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1457 - C1467.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Thibault, P. Tardif, and G. Lapalme
Comparative Specificity of Platelet {alpha}IIb{beta}3 Integrin Antagonists
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 690 - 696.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
G. Thibault
Sodium Dodecyl Sulfate-Stable Complexes of Echistatin and RGD-Dependent Integrins: A Novel Approach to Study Integrins
Mol. Pharmacol., November 1, 2000; 58(5): 1137 - 1145.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Gunasegaram, R. S. Haworth, D. J. Hearse, and M. Avkiran
Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors
Circ. Res., November 12, 1999; 85(10): 919 - 930.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. Robert, C. Heymes, J.-S. Silvestre, A. Sabri, B. Swynghedauw, and C. Delcayre
Angiotensin AT1 Receptor Subtype as a Cardiac Target of Aldosterone : Role in Aldosterone-Salt–Induced Fibrosis
Hypertension, April 1, 1999; 33(4): 981 - 986.
[Abstract] [Full Text] [PDF]